4.65 USD
↘ 0.13 (2.72%)AT CLOSE (03:59 PM EDT)
Aligos Therapeutics, Inc. Common Stock
ALGSNASDAQ • USD
4.70
↗ 0.04 (0.97%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
4.70
↗ 0.04 (0.97%)
Market: CLOSED
ALGS is currently priced at $4.67. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Oct 26, 2026.
Open?$4.98
High?$4.98
Low?$4.55
Prev. Close?$4.78
Volume?33.0K
Avg. Volume?40.1K
VWAP?$4.69
Rel. Volume?0.82x
Bid / Ask
Bid?$3.91 × 100
Ask?$5.68 × 100
Spread?$1.77
Midpoint?$4.80
Valuation & Ratios
Market Cap?29.8M
Shares Out?6.2M
Float?5.6M
Float %?89.2%
P/E Ratio?N/A
P/B Ratio?0.94
EPS?-$12.16
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
Themes
Employees
82
Market Cap
29.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2020-10-16
Address
ONE CORPORATE DR., 2ND FLOOR
SOUTH SAN FRANCISCO, CA 94080
Phone: (800) 466-6059
SOUTH SAN FRANCISCO, CA 94080
Phone: (800) 466-6059
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?0
Momentum?50
Short Sent.?48
Piotroski F-Score?4/9Mixed
Altman Z-Score?-16.40Distress
Confidence?58%Low
Short InterestVery High
Short % of Float?12.70%High
Short Interest?707.5K
Days to Cover?21.7
Free Float5.6M
Avg Daily Volume32.5K
Settlement Date2026-10-15
Financial Health
Current Ratio?2.19Strong
Quick Ratio?2.19Strong
Cash Ratio?1.07Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.94CHEAP▾
Peers100
S&P97
P/S?0.95CHEAP▾
Peers100
S&P87
P/FCF?N/A▾
EV/EBITDA?0.0CHEAP▾
Peers100
S&P97
EV/Sales?-0.01CHEAP▾
S&P97
Returns & Efficiency
ROE?-238.2%WEAK▾
S&P3
ROA?-114.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-94523000
Enterprise Value?$-468013
Fundamentals ratios updated end of day